A FOXM1 related long non-coding RNA contributes to gastric cancer cell migration

Molecular and Cellular Biochemistry

Volumn 406, Issue 1-2, 2015, Pages 31-41

  Cai, Hui ^a   Chen, Jingde ^a   He, Bin ^a   Li, Qiang ^a   Li, Yandong ^a   Gao, Yong ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cell migration; FOXM1; Gastric cancer; LncRNA

Indexed keywords

LONG UNTRANSLATED RNA; RNA FRLNC1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXM1; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; NUCLEAR PROTEIN; TWIST1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GASTRIC CANCER CELL LINE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG METASTASIS; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH CANCER; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; SECONDARY; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; RNA, LONG NONCODING; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; TWIST TRANSCRIPTION FACTOR;

EID: 84945951569     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2421-3     Document Type: Article

References (33)

1. Tanpakushitsu HM, Koso K et al (2004) Finishing the euchromatic sequence of the human genome. Nature 431:931–945. doi:10.1038/nature03001
2. Tahira AC, Kubrusly MS, Faria MF, Dazzani B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado MC, Reis EM (2011) Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol Cancer 10:141. doi:10.1186/1476-4598-10-141
3. Ponting CP, Belgard TG (2010) Transcribed dark matter: meaning or myth? Hum Mol Genet 19:R162–R168. doi:10.1093/hmg/ddq362
4. Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10:155–159. doi:10.1038/nrg2521
5. Brosnan CA, Voinnet O (2009) The long and the short of noncoding RNAs. Curr Opin Cell Biol 21:416–425. doi:10.1016/j.ceb.2009.04.001
6. Rinn JL, Chang HY (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145–166. doi:10.1146/annurev-biochem-051410-092902
7. Mattick JS (2009) The genetic signatures of noncoding RNAs. PLoS Genet 5:e1000459. doi:10.1371/journal.pgen.1000459
8. Ounzain S, Pezzuto I, Micheletti R, Burdet F, Sheta R, Nemir M, Gonzales C, Sarre A, Alexanian M, Blow MJ, May D, Johnson R, Dauvillier J, Pennacchio LA, Pedrazzini T (2014) Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease. J Mol Cell Cardiol 76:55–70. doi:10.1016/j.yjmcc.2014.08.009
9. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan X, Ruan Y, Lassmann T, Carninci P, Brown JB, Lipovich L, Gonzalez JM, Thomas M, Davis CA, Shiekhattar R, Gingeras TR, Hubbard TJ, Notredame C, Harrow J, Guigo R (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22:1775–1789. doi:10.1101/gr.132159.111
10. Marques AC, Ponting CP (2009) Catalogues of mammalian long noncoding RNAs: modest conservation and incompleteness. Genome Biol 10:R124. doi:10.1186/gb-2009-10-11-r124
11. Yang G, Lu X, Yuan L (2014) LncRNA: a link between RNA and cancer. Biochim Biophys Acta 1839:1097–1109. doi:10.1016/j.bbagrm.2014.08.012
12. Lu L, Zhu G, Zhang C, Deng Q, Katsaros D, Mayne ST, Risch HA, Mu L, Canuto EM, Gregori G, Benedetto C, Yu H (2012) Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res Treat 136:875–883. doi:10.1007/s10549-012-2314-z
13. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464:1071–1076. doi:10.1038/nature08975
14. Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y, Fang G (2013) Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol 139:437–445. doi:10.1007/s00432-012-1324-x
15. He X, Tan X, Wang X, Jin H, Liu L, Ma L, Yu H, Fan Z (2014) C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol 35:12181–12188. doi:10.1007/s13277-014-2526-4
16. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, Liu F, Pan W, Wang TT, Zhou CC, Wang SB, Wang YZ, Yang Y, Yang N, Zhou WP, Yang GS, Sun SH (2014) A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25:666–681. doi:10.1016/j.ccr.2014.03.010
17. Li W, Kang Y (2014) A new Lnc in metastasis: long noncoding RNA mediates the prometastatic functions of TGF-beta. Cancer Cell 25:557–559. doi:10.1016/j.ccr.2014.04.014
18. Qi P, Du X (2013) The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 26:155–165. doi:10.1038/modpathol.2012.160
19. Yamamoto H, Watanabe Y, Maehata T, Morita R, Yoshida Y, Oikawa R, Ishigooka S, Ozawa S, Matsuo Y, Hosoya K, Yamashita M, Taniguchi H, Nosho K, Suzuki H, Yasuda H, Shinomura Y, Itoh F (2014) An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa. World J Gastroenterol 20:3927–3937. doi:10.3748/wjg.v20.i14.3927
20. Smith MG, Hold GL, Tahara E, El-Omar EM (2006) Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12:2979–2990
21. Okada K, Fujiwara Y, Takahashi T, Nakamura Y, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Mori M, Doki Y (2013) Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer. Ann Surg Oncol 20:1035–1043. doi:10.1245/s10434-012-2680-0
22. Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D, Huang S, Tan D, Xie K (2009) Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res 69:3501–3509. doi:10.1158/0008-5472.can-08-3045
23. Zhang Y, Zhang N, Dai B, Liu M, Sawaya R, Xie K, Huang S (2008) FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res 68:8733–8742. doi:10.1158/0008-5472.can-08-1968
24. Zeng J, Wang L, Li Q, Li W, Bjorkholm M, Jia J, Xu D (2009) FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. J Pathol 218:419–427. doi:10.1002/path.2530
25. Huang C, Du J, Xie K (2014) FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis. Biochim Biophys Acta 1845:104–116. doi:10.1016/j.bbcan.2014.01.002
26. Bella L, Zona S, de Moraes GN, Lam EW (2014) FOXM1: a key oncofetal transcription factor in health and disease. Semin Cancer Biol 29c:32–39. doi:10.1016/j.semcancer.2014.07.008
27. Lam EW, Brosens JJ, Gomes AR, Koo CY (2013) Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer 13:482–495. doi:10.1038/nrc3539
28. Behren A, Muhlen S, Acuna Sanhueza GA, Schwager C, Plinkert PK, Huber PE, Abdollahi A, Simon C (2010) Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion. Oncogene 29:1519–1530. doi:10.1038/onc.2009.436
29. Fang XY, Pan HF, Leng RX, Ye DQ (2015) Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett 356:357–366. doi:10.1016/j.canlet.2014.11.005
30. Bartscht T, Lehnert H, Gieseler F, Ungefroren H (2012) The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells. Cancer Chemother Pharmacol 70:221–230. doi:10.1007/s00280-012-1904-0
31. Ge R, Rajeev V, Ray P, Lattime E, Rittling S, Medicherla S, Protter A, Murphy A, Chakravarty J, Dugar S, Schreiner G, Barnard N, Reiss M (2006) Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo. Clin Cancer Res 12:4315–4330. doi:10.1158/1078-0432.ccr-06-0162
32. Mohammad KS, Javelaud D, Fournier PG, Niewolna M, McKenna CR, Peng XH, Duong V, Dunn LK, Mauviel A, Guise TA (2011) TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Res 71:175–184. doi:10.1158/0008-5472.can-10-2651
33. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927–939. doi:10.1016/j.cell.2004.06.006